F00-F99
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion is transdiagnostic, meaning that participants are eligible regardless of the specific (suspected) disorder, provided that an indication for outpatient psychotherapy has been established during the initial assessment session. Additional inclusion criteria are sufficient German language proficiency and written informed consent from both the participants and their legal guardians.
Exclusion criteria
Exclusion criteria: Patients will be excluded if they present with acute suicidality or other crisis conditions requiring immediate treatment, manifest psychotic disorders, severe intellectual disability, or significant cognitive or language impairments that would prevent participation in the assessments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes of the study are: 1) the level of psychopathological symptoms, including general psychological distress, depressive symptoms, anxiety symptoms, and aggressive behavior. These outcomes will be assessed using standardized questionnaires completed by adolescents (self-report) and their parents (parent report) (SDQ, PSC-D, PHQ-A, SCARED, RPQ) and 2) changes in the adolescents’ individual symptom networks, assessed using PECAN-CA based on adolescent self-report. Primary outcomes will be assessed at two time points: before the start of psychotherapy (pre-treatment) and immediately after the completion of psychotherapy (post-treatment). In addition, repeated measurements will be conducted during therapy. The individual symptom network will be reassessed using PECAN-CA every five therapy sessions. Furthermore, the severity of individually relevant symptoms will be assessed at each therapy session. | — |
Secondary
| Measure | Time frame |
|---|---|
| At the same assessment time points (pre- and post-treatment), child quality of life (KINDL) and illness perceptions (IPQ-R) will be assessed via adolescent self-report. In addition, feasibility questions regarding the use of symptom networks will be collected during each therapy session. At post-treatment, an additional feasibility questionnaire assessing the acceptability of the personalization approach based on symptom networks will be administered; “In addition, speech samples will be analyzed to investigate whether the prioritized symptoms are reflected in participants’ language use and whether changes in symptomatology over time are mirrored in linguistic features. | — |
Countries
Germany
Contacts
JGU Mainz